In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 236 for your search:
Drug:  BCG vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: CNR-9505, EU-95023
2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 25 to 65
Sponsor:
Protocol IDs: DFCI-75116
3.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: EORTC-LAM-4
4.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-CR1, NCI-V88-419A
5.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-CR2, NCI-V88-419B
6.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-CR3, NCI-V88-419C
7.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-CR4, NCI-V88-419D
8.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-CR5, NCI-V88-419E
9.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-M1, NCI-V88-420A
10.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-M2, NCI-V88-420B
11.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-M3, NCI-V88-420C
12.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-S1, NCI-V88-421A
13.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-S2, NCI-V88-421B
14.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-S3, NCI-V88-421C
15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GBMC-M/1600/0015, UPJOHN-M/1600/0015, NCI-V95-0656
16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 75
Sponsor:
Protocol IDs: WHO-MEL-TRIAL6, EU-95043
17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 85 and under
Sponsor: Other
Protocol IDs: CDR0000065529, EORTC-30962, NCT00002990
18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-08971, UCLA-9902001, NCT00003279
19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: JWCI-MC-4-001, CV-MMAIT-4-001, RPCI-DS-98-16, NCI-G98-1492, NCT00052156
20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 90
Sponsor: Other
Protocol IDs: SAKK 06/98, SWS-SAKK-06/98, EU-98075, NCT00003779
21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: JWCI-MC-3-001A, CV-MMAIT-3-001, NCI-V99-1576, NCT00052130
22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-08971B, NCT00006352
23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor:
Protocol IDs: SEG-77AML318, SEG-77AML0103
24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 16
Sponsor: NCI
Protocol IDs: SWOG-7315/16
25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: SWOG-7416/17, MDAR-3
1     
New Search